Erythrocytosis · elevated hemoglobin & hematocrit
Expected on elevated androgens. Monitored closely. No dose reduction indicated.
Not a major concern, and it needs context. Elevated androgens drive erythropoiesis. The body produces more red cells in response to higher testosterone. That's expected physiology on this protocol, not a failure of it. I manage it by monitoring trend and symptoms closely, using CPAP (which addresses the sleep-disordered-breathing contribution), and keeping an eye on blood pressure, which stays well regulated. No dose reduction indicated here. If blood pressure were climbing or I were symptomatic (headaches, visual changes, unusual fatigue), the plan would change. None of that is happening. The plan is to watch.